Synergistic interaction between an adenosine antagonist and a D1 dopamine agonist on rotational behavior and striatal c-Fos induction in 6-hydroxydopamine-lesioned rats

Brain Research

Volumn 743, Issue 1-2, 1996, Pages 124-130

  Pollack, Alexia E ^a,b   Fink, J Stephen ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

adenosine receptor A2; c Fos; DMPX; dopamine receptor D1; SKF38393; striatum

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; ADENOSINE RECEPTOR BLOCKING AGENT; DMPX; DOPAMINE 1 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; OXIDOPAMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INJURY; CIRCLING BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; IMMUNOHISTOCHEMISTRY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; RAT;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ANIMALS; CORPUS STRIATUM; DOPAMINE AGONISTS; DRUG SYNERGISM; FUNCTIONAL LATERALITY; MALE; MOTOR ACTIVITY; NEUROTOXINS; OXIDOPAMINE; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, PURINERGIC P1; ROTATION; THEOBROMINE;

EID: 0030447366     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)01036-0     Document Type: Article

References (40)

1. Albin, R.L., Young, A.B. and Penney, J.B., The functional anatomy of basal ganglia disorders, Trends Neurosci., 12 (1989) 366-375.
2. Alexander, S.P. and Reddington, M., The cellular localization of adenosine receptors in rat neostriatum, Neuroscience, 28 (1989) 645-651.
3. 2+ influx, Br. J. Pharmacol., 98(1989) 225-235.
4. 2a purine receptors regulate striatal acetylcholine release, J. Neurochem., 55 (1990) 31-37.
5. Dragnow, M., Leah, J.D. and Faull, R.L.M., Prolonged and selective induction of Fos-related antigen(s) in striatal neurons after 6-hydroxydopamine lesions of the rat substantia nigra pars compacta, Mol. Brain Res., 10 (1991) 355-358.
6. Ferre, S., Fuxe, K., Von Euler, G., Johansson, B. and Fredholm, B.B., Adenosine-dopamine interactions in the brain, Neuroscience, 51 (1992) 501-512.
7. Ferre, S., Herrera-Marschitz, M., Grabowska-Anden, M., Casas, M., Ungerstedt, U. and Anden, N.-E., Post-synaptic dopamine/adenosine interaction: II Postsynaptic dopamine agonism and adenosine antagonism of methylxanthines in short-term reserpinized mice, Eur. J. Pharmacol., 192 (1991) 31-37.
8. Ferre, S., O'Conner, W.T., Fuxe, K. and Ungerstedt, U., The striatopallidal neuron: a main locus for adenosine-dopamine interactions in the brain, J. Neurosci., 13 (1993) 5402-5406.
9. 2 receptors in the ventral striopallidal system. Implications for the treatment of Schizophrenia, Neuroscience, 63 (1994) 765-773.
10. 1 receptors, Neuroreport, 6 (1994) 73-76.
11. 2 receptors in rat striatal membranes, Proc. Natl. Acad. Sci. USA, 88 (1991) 7238-7241.
12. 2 dopamine receptors in rats striatum, Mol. Brain Res., 14 (1992) 186-195.
13. Fredholm, B.B., Herrera-Marschitz, M., Jonzon, B., Lindstrom, K., Ungerstedt, U., On the mechanism by which methylxanthines enhance apomorphine-induced rotation behavior in the rat, Pharmacol. Biochem. Behav., 19 (1983) 535-541.
14. Fuxe, K. and Ungerstedt, U., Action of caffeine and theophylline on supersensitive dopamine receptors: considerable enhancement of receptor response to treatment with dopa and dopamine receptor agonists, Med. Biol., 52 (1974) 48-54.
15. Garrett, B.E. and Holtzman, S.G., Does adenosine receptor blockade mediate caffeine-induced rotational behavior?, J. Pharmacol. Exp. Ther., 274 (1995) 207-214.
16. 2 dopamine receptor regulated gene expression of striatonigral and striatopallidal neurons, Science, 250 (1990) 1429-1432.
17. 1-containing neurons, J. Neurosci., 15 (1995) 8167-8176.
18. 1 receptors to striatonigral neurons, Brain Res., 528 (1990) 317-322.
19. 1 receptor binding in the striatum following a selective lesion of striatopallidal neurons, Brain Res., 590 (1992) 305-310.
20. Herrera-Marschitz, M., Casas, M. and Ungerstedt, U., Caffeine produces contralateral rotation in rats with unilateral dopamine denervation: comparisons with apomorphine-induced responses, Psychopharmacology, 94 (1988) 38-45.
21. Jain, M., Staines, W.A., Iadarola, M.J. and Robertson, G.S., Destruction of the nigrostriatal pathway increases Fos-like immunoreactivity predominantly in striatopallidal neurons, Mol. Brain Res., 19 (1993) 156-160.
22. Jiang, H., Jackson-Lewis, V., Muthane, U., Dollison, A., Ferreira, M., Espinosa, A., Parsons, B. and Przeborski, S., Adenosine receptor antagonists potentiate dopamine receptor agonist-induced rotational behavior in 6-hydroxydopamine-lesioned rats, Brain Res., 613 (1993) 347-351.
23. 2 dopamine receptor synergy in striatum: effects of intrastriatal infusions of dopamine agonists and antagonists on immediate early gene expression, Neuroscience, 66 (1995) 903-913.
24. Le Moine, C., Normand, E., Guitteny, A.F., Fouque, B., Teoule, R. and Bloch, B., Dopamine receptor gene expression by enkephalin neurons in the rat forebrain, Proc. Natl. Acad. Sci. USA, 87 (1990) 230-234.
25. 2 receptor modulation of electrically evoked endogenous GABA release in slices of rat globus pallidus, J., Neurochem., 60 (1993) 2334-2337.
26. 2 receptors in unilaterally 6-hydroxydopamine-lesioned rats, Eur. J. Pharmacol., 251(1994) 21-25.
27. 2 receptors stimulate c-fos expression in striatal neurons of 6-hydroxydopamine-lesioned rats, Neuroscience, 67 (1995) 49-55.
28. Morgan, J.I. and Curran, T., Stimulus-transcription coupling in neurons: role of cellular immediate early genes, Trends Neurosci., 12 (1989) 459-462.
29. 2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease, J. Neurosci., 12 (1992) 3729-3742.
30. Paxinos, G. and Watson, C., The Rat Brain in Stereotaxic Coordinates, 2nd edn., Academic Press, San Diego, CA, 1986.
31. 2 dopamine-dependent activation of Fos in the striatopallidal pathway, Neuroscience, 68 (1995) 721-728.
32. 2 dopamine receptor mRNA in striatal output pathways following a selective lesion of striatonigral neurons, Brain Res., 631 (1993) 161-166.
33. 2 dopamine agonists on turning behavior in rats, Brain Res., 384 (1986) 387-390.
34. 2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons, Neuroscience, 49 (1990) 285-296.
35. 1 dopamine receptor-activated c-fos, Brain Res., 523 (1992) 288-290.
36. Sagar, S.M., Sharp, F.R. and Curran, T., Expression of c-fos protein in brain: metabolic mapping at the cellular level, Science, 240 (1988) 1328-1331.
37. 2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemical study, J. Neurochem., 57 (1991) 1062-1067.
38. 2 receptors regulate the gene expression of striatopallidal and striatonigral neurons, J. Neurosci., 13 (1993) 1080-1087.
39. Seale, T.W., Abla, K.A., Shamim, M.T., Carney, J.M. and Daly, J.W., 3,7-Dimethyl-1-propargylxanthine: a potent and selective in vivo antagonist of adenosine analogs, Life Sci., 43 (1988) 1671-1684.
40. 2 agonists on amphetamine-induced locomotion and c-Fos in the striatum and nucleus accumbens, Brain Res., 707 (1996) 75-80.